Clinical Trial Update: Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating a treatment for aromatase inhibitor–associated arthralgia in breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer, Arthralgia | Phase 2 | Status: WITHDRAWN